ONWARD

Eindhoven, Netherlands Founded: 2014 • Age: 12 yrs
Therapeutic devices for spinal cord injuries are developed and delivered.
Request Access

About ONWARD

ONWARD is a company based in Eindhoven (Netherlands) founded in 2014.. ONWARD has raised $35.04 million across 12 funding rounds from investors including Otto Bock, EQT and HHS. ONWARD offers products and services including ARC EX Therapy, ARC IM, and Brain-Computer Interface. ONWARD operates in a competitive market with competitors including SetPoint Medical, Nalu Medical, Atlantic Therapeutics, Synchron and CyMedica Ortho, among others.

  • Headquarter Eindhoven, Netherlands
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $35.04 M (USD)

    in 12 rounds

  • Latest Funding Round
    $59.17 M (USD), Post-IPO

    Oct 28, 2025

  • Investors
    Otto Bock

    & 12 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ONWARD

ONWARD offers a comprehensive portfolio of products and services, including ARC EX Therapy, ARC IM, and Brain-Computer Interface. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Non-invasive device to improve hand function in spinal cord injury patients.

Implantable system for restoring movement in neurological conditions.

Technology for brain-controlled device interaction in paralysis cases.

Funding Insights of ONWARD

ONWARD has successfully raised a total of $35.04M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $59.17 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 12
  • Last Round Post-IPO — $59.2M
  • First Round

    (01 Aug 2014)

  • Investors Count 13
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2025 Amount Post-IPO - ONWARD Valuation

investors

Nov, 2024 Amount Grant - ONWARD Valuation

investors

Oct, 2024 Amount Post-IPO - ONWARD Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ONWARD

ONWARD has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Otto Bock, EQT and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
EQT is recognized as a global investment organization focused on value creation.
Founded Year Domain Location
AI, deeptech, and healthcare tech companies are funded by Inkef.
Founded Year Domain Location
Infrastructure and venture capital funding is provided in key sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ONWARD

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ONWARD

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Onward Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ONWARD

ONWARD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Nalu Medical, Atlantic Therapeutics, Synchron and CyMedica Ortho, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable neuromodulation devices are developed for inflammatory diseases.
domain founded_year HQ Location
Developer of a neurostimulation system for managing intractable chronic pain
domain founded_year HQ Location
Non-invasive wearable devices for pelvic floor strengthening are developed.
domain founded_year HQ Location
Implantable bioelectronics are developed for neurological condition treatments.
domain founded_year HQ Location
Neuromuscular electrical stimulation platform to prevent Muscle atrophy after orthopedic surgeries
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Onward

Frequently Asked Questions about ONWARD

When was ONWARD founded?

ONWARD was founded in 2014.

Where is ONWARD located?

ONWARD is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.

Who is the current CEO of ONWARD?

Dave Marver is the current CEO of ONWARD.

Is ONWARD a funded company?

ONWARD is a funded company, having raised a total of $35.04M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $24.26M, raised on Aug 01, 2014.

What does ONWARD do?

ONWARD was founded in 2014 in Eindhoven, Netherlands, and operates in the medical device sector. Focus is placed on developing ARC therapy, which is delivered through implantable or external systems. Programmed stimulation of the spinal cord is utilized to restore movement and associated functions in patients with spinal cord injuries. Operations center on therapeutic innovation for neurological conditions.

Who are the top competitors of ONWARD?

ONWARD's top competitors include SetPoint Medical, Synchron and Nalu Medical.

What products or services does ONWARD offer?

ONWARD offers ARC EX Therapy, ARC IM, and Brain-Computer Interface.

Who are ONWARD's investors?

ONWARD has 13 investors. Key investors include Otto Bock, EQT, HHS, Gimv, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available